Advertisement

ARIKAYCE (amikacin liposome inhalation suspension)

No Defense - 1

NEW YORK
2019
2019
Entrant Company
Area 23, An FCB Health Network Company
Medium
Print & Out of Home Technique (Pharmaceutical)
Category
Art Direction
Entry Type
Direct-to-Professionals
Thumbnail for No Defense - 1
View Fullscreen

Items

Credits
Agency NetworkFCB Health Network
Advertiser BrandInsmed - ARIKAYCE
Entrant CompanyArea 23, An FCB Health Network Company
Animation CompanyZombie Studio
CCOTim Hawkey
SVP, Group Creative DirectorChris Bernesby
SVP, Creative DirectorJoe Capanear
VP, Creative DirectorMike McKeever
VP, Associate Creative DirectorZuzana Zaloudek
Group Art SupervisorOlga Demeshchik
ProducerRenee Jung
SVP, Group Management DirectorRobb Brady
VP, Account DirectorMartha Simpson
Account DirectorJack O’Shaughnessy
Strategic Planning DirectorGreg Yellin
CGI DesignZombie Studios
TypographerKevin Cantrell
Typography ProducerErik Attkisson

This 2019 Clio Health Bronze winning entry titled 'No Defense - 1' was entered for ARIKAYCE (amikacin liposome inhalation suspension) by Area 23, An FCB Health Network Company, New York, part of agency network: FCB Health Network. The piece was submitted to the medium: Print & Out of Home Technique (Pharmaceutical) within the entry type: Direct-to-Professionals and the category: Art Direction.

Advertisement
Advertisement